Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,4215 EUR | -10,98% | -16,04% | -94,82% |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 10,99 mln. 11,72 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -23 mln. -24,54 mln. | Nettowinst (verlies) 2024 * | -18 mln. -19,21 mln. | EV/omzet 2023 * | - |
Nettoliquiditeiten 2023 * | 24,1 mln. 25,71 mln. | Nettoliquiditeiten 2024 * | 19,55 mln. 20,86 mln. | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,45
x | K/w-verhouding 2024 * |
-0,59
x | Werknemers | 15 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 66,82% |
Recentste transcriptie over Vivoryon Therapeutics N.V.
1 dag | -10,98% | ||
1 week | -16,04% | ||
Lopende maand | -21,94% | ||
1 maand | -24,60% | ||
3 maanden | -94,66% | ||
6 maanden | -96,16% | ||
Lopend jaar | -94,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank Weber
CEO | Chief Executive Officer | 64 | 01-01-12 |
Anne Doering
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 56 | 31-08-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 74 | 01-01-07 | |
Director/Board Member | 54 | 01-01-07 | |
Anne Doering
DFI | Director of Finance/CFO | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 0,4215 | -10,98% | 374 611 |
16-04-24 | 0,4735 | -1,35% | 114 394 |
15-04-24 | 0,48 | -3,03% | 177 586 |
12-04-24 | 0,495 | -1,20% | 128 496 |
11-04-24 | 0,501 | -0,60% | 95 643 |
Real Time Euronext Amsterdam, 17 april 2024 om 17:35 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-94,82% | 13,12 mln. | |
-1,78% | 41,71 mld. | |
+47,70% | 41,56 mld. | |
+4,01% | 39,74 mld. | |
-15,14% | 25,61 mld. | |
+3,16% | 24,26 mld. | |
-24,08% | 18,55 mld. | |
-2,67% | 11,93 mld. | |
+24,76% | 11,93 mld. | |
+7,01% | 10,91 mld. |